• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯塔伊夫三级医疗医院非酒精性脂肪性肝病的患病率及预测因素:一项回顾性研究

Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study.

作者信息

Alamri Abdulhakeem S, Alhomrani Majid, Alsanie Walaa F, Alghamdi Ahmad Joman, Alghamdi Zaher M, Al-Subaie Abdualmohsen A, Alharthi Yasser A, Alqurashi Hesham H, Asdaq Syed Mohammed Basheeruddin

机构信息

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.

Centre of Biomedical Sciences Research (CBSR), Deanship of Scientific Research, Taif University, Saudi Arabia.

出版信息

Saudi J Biol Sci. 2021 Sep;28(9):4921-4925. doi: 10.1016/j.sjbs.2021.05.063. Epub 2021 Jun 1.

DOI:10.1016/j.sjbs.2021.05.063
PMID:34466067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8381033/
Abstract

BACKGROUND

The prevalence of nonalcoholic fatty liver disease (NAFLD) in Saudi Arabia is predicted to exceed 30% by 2030. NAFLD leads to liver fibrosis, thus increasing morbidity and health care burden. Obesity and diabetes have been strongly associated with NAFLD in different cities in Saudi Arabia.

OBJECTIVES

Therefore, we aim to determine the prevalence rate of NAFLD and specific risk factors for NAFLD among patients of tertiary care hospital of Taif city.

MATERIAL AND METHODS

We retrospectively analyzed the medical records of patients for two years, between Feb 2017 and Feb 2019, (n = 100) referred to the hepatology clinic at King Abdulaziz Specialist Hospital in Taif. The diagnosis of NAFLD was based on the radiology report for patients who were aged >20 years old. Other parameters including fasting blood glucose (FBG), platelets count, alanine transaminase (ALT), aspartate transaminase (AST) and total bilirubin were statistically analyzed.

RESULTS

We found that 40% (P < 0.05) of all patients had NAFLD. The results revealed that a significantly high number of patients with NAFLD have high FBG levels (75%, P < 0.0001) and total bilirubin (P < 0.05). Meanwhile, platelet count was significantly reduced in patients with NAFLD (P < 0.05).

CONCLUSION

NAFLD can be a serious health problem in the Taif region. In addition, high FBG is a significant specific risk factor for NAFLD. Health care providers should pay more attention to limiting the prevalence of NAFLD and its risk factors.

摘要

背景

预计到2030年,沙特阿拉伯非酒精性脂肪性肝病(NAFLD)的患病率将超过30%。NAFLD会导致肝纤维化,从而增加发病率和医疗负担。在沙特阿拉伯的不同城市,肥胖和糖尿病与NAFLD密切相关。

目的

因此,我们旨在确定塔伊夫市三级护理医院患者中NAFLD的患病率以及NAFLD的特定危险因素。

材料与方法

我们回顾性分析了2017年2月至2019年2月期间转诊至塔伊夫阿卜杜勒阿齐兹专科医院肝病诊所的患者(n = 100)的两年病历。NAFLD的诊断基于年龄>20岁患者的放射学报告。对包括空腹血糖(FBG)、血小板计数、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和总胆红素在内的其他参数进行了统计分析。

结果

我们发现所有患者中有40%(P < 0.05)患有NAFLD。结果显示,NAFLD患者中血糖水平高(75%,P < 0.0001)和总胆红素高(P < 0.05)的患者数量显著增加。同时,NAFLD患者的血小板计数显著降低(P < 0.05)。

结论

NAFLD在塔伊夫地区可能是一个严重的健康问题。此外,高血糖是NAFLD的一个重要特定危险因素。医疗服务提供者应更加关注限制NAFLD及其危险因素的流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/80b05144a398/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/d8ef6078aeee/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/99dd5383f944/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/5ce4706fa333/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/83f4966f5308/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/80b05144a398/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/d8ef6078aeee/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/99dd5383f944/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/5ce4706fa333/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/83f4966f5308/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6858/8381033/80b05144a398/gr5.jpg

相似文献

1
Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study.沙特阿拉伯塔伊夫三级医疗医院非酒精性脂肪性肝病的患病率及预测因素:一项回顾性研究
Saudi J Biol Sci. 2021 Sep;28(9):4921-4925. doi: 10.1016/j.sjbs.2021.05.063. Epub 2021 Jun 1.
2
Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study.沙特非酒精性脂肪性肝病患者的流行病学、临床和生化特征:一项基于医院的研究。
Ann Saudi Med. 2012 May-Jun;32(3):288-92. doi: 10.5144/0256-4947.2012.288.
3
Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah.吉达阿卜杜勒阿齐兹国王大学医院慢性肝病患者中非酒精性脂肪性肝病的患病率及临床特征
Saudi J Med Med Sci. 2020 May-Aug;8(2):118-124. doi: 10.4103/sjmms.sjmms_272_19. Epub 2020 Apr 17.
4
Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.利用非酒精性脂肪性肝病活动评分标准对糖尿病(2型糖尿病)和非糖尿病非酒精性脂肪性肝病患者进行组织病理学差异分析。
World J Hepatol. 2015 Nov 8;7(25):2610-8. doi: 10.4254/wjh.v7.i25.2610.
5
Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia.沙特阿拉伯一家三级医疗中心非酒精性脂肪性肝病的患病率
Cureus. 2023 Oct 29;15(10):e47896. doi: 10.7759/cureus.47896. eCollection 2023 Oct.
6
Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.2017 - 2030年沙特阿拉伯和阿拉伯联合酋长国的非酒精性脂肪性肝病负担
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):211-219. doi: 10.4103/sjg.SJG_122_18.
7
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
8
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
9
Prevalence and Risk Factors of Diabetic Nephropathy Among Saudi Type-1 Diabetic Patients in Taif City, Saudi Arabia.沙特阿拉伯塔伊夫市1型糖尿病患者中糖尿病肾病的患病率及危险因素
Diabetes Metab Syndr Obes. 2023 Nov 9;16:3609-3616. doi: 10.2147/DMSO.S432700. eCollection 2023.
10
Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.学龄儿童非酒精性脂肪性肝病的患病率、危险因素及预测因素:埃及亚历山大市一项基于医院的研究
Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.

引用本文的文献

1
Targeted therapeutic strategies as alternative and sustainable treatment options for obesity-induced steatohepatitis.靶向治疗策略作为肥胖诱导性脂肪性肝炎的替代和可持续治疗选择。
Rev Endocr Metab Disord. 2025 Jun 25. doi: 10.1007/s11154-025-09980-7.
2
Experience of pediatric liver disease at a university hospital in Western Saudi Arabia.沙特阿拉伯西部一家大学医院的儿科肝病治疗经验。
Saudi Med J. 2025 May;46(5):567-570. doi: 10.15537/smj.2025.46.5.20240854.
3
Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt.

本文引用的文献

1
Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study.1990 - 2017年全球、区域和国家层面非酒精性脂肪性肝病的患病率趋势:一项基于人群的观察性研究。
BMJ Open. 2020 Aug 3;10(8):e036663. doi: 10.1136/bmjopen-2019-036663.
2
Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study.在血脂水平正常的非肥胖中国人群中,空腹血糖与非酒精性脂肪肝之间的关系:一项前瞻性队列研究。
Lipids Health Dis. 2020 Jun 20;19(1):145. doi: 10.1186/s12944-020-01326-3.
3
埃及医科学生中代谢相关脂肪性肝病的发病率及危险因素
Sci Rep. 2025 Apr 18;15(1):13470. doi: 10.1038/s41598-025-95753-w.
4
Metformin: Beyond Type 2 Diabetes Mellitus.二甲双胍:超越2型糖尿病
Cureus. 2024 Oct 17;16(10):e71730. doi: 10.7759/cureus.71730. eCollection 2024 Oct.
5
Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia.沙特阿拉伯一家三级医疗中心非酒精性脂肪性肝病的患病率
Cureus. 2023 Oct 29;15(10):e47896. doi: 10.7759/cureus.47896. eCollection 2023 Oct.
6
Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with non-alcoholic fatty liver disease: A secondary prospective cohort study in non-obese Chinese adults.γ-谷氨酰转移酶与高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病呈非线性关联:一项针对非肥胖中国成年人的二次前瞻性队列研究。
Front Med (Lausanne). 2022 Nov 17;9:995749. doi: 10.3389/fmed.2022.995749. eCollection 2022.
7
Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.瞬时弹性成像用于评估 2 型糖尿病患者非酒精性脂肪性肝病的患病率:来自 CORDIAL 队列研究的证据。
Saudi J Gastroenterol. 2022 Nov-Dec;28(6):426-433. doi: 10.4103/sjg.sjg_73_22.
8
Evaluating the knowledge on microbiome and dysbiosis in allergic diseases among medical sciences students in Saudi Arabia.评估沙特阿拉伯医科学生对过敏性疾病中微生物群和生态失调的了解。
Clin Mol Allergy. 2022 Jan 31;20(1):2. doi: 10.1186/s12948-022-00168-x.
Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
脂肪肝指数和代谢因素在体检瘦人群体中非酒精性脂肪肝预测中的作用。
Clin Transl Gastroenterol. 2019 May 22;10(5):1-8. doi: 10.14309/ctg.0000000000000042.
4
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.非酒精性脂肪性肝病的无创评估:当前证据与实践
World J Gastroenterol. 2019 Mar 21;25(11):1307-1326. doi: 10.3748/wjg.v25.i11.1307.
5
Non-alcoholic fatty liver disease - A global public health perspective.非酒精性脂肪性肝病——全球公共卫生视角。
J Hepatol. 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9.
6
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.全球视角下的非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251.
7
Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.2017 - 2030年沙特阿拉伯和阿拉伯联合酋长国的非酒精性脂肪性肝病负担
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):211-219. doi: 10.4103/sjg.SJG_122_18.
8
Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients.血小板计数和血小板指数在非酒精性脂肪性肝病患者肝纤维化无创评估中的诊断准确性。
Can J Gastroenterol Hepatol. 2017;2017:6070135. doi: 10.1155/2017/6070135. Epub 2017 Dec 31.
9
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.非酒精性脂肪性肝纤维化可独立预测非酒精性脂肪性肝病的死亡率。
Hepatol Commun. 2017 Jun 6;1(5):421-428. doi: 10.1002/hep4.1054. eCollection 2017 Jul.
10
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.